Effect of Hydroxycitrate on Urine Chemistry
NCT03348228 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2022-01-26
Summary
Hydroxycitrate (HCA) is a compound extracted from the fruit, Garcinia Cambogia. Hydroxycitrate supplements are available over the counter and are primarily promoted as a weight loss supplement. There has been recent evidence that hydroxycitrate is a potent inhibitor of calcium oxalate crystal growth and can lead to the dissolution of the crystals. The purpose of this research study is to study the effect of Hydroxycitrate (HCA) supplements on HCA urinary excretion and on urine chemistries in kidney stone formers and normal subjects.
Conditions
- Nephrolithiasis
Interventions
- DIETARY_SUPPLEMENT
-
Hydroxycitrate (HCA)
Hydroxycitrate supplements are available over the counter and are primarily promoted as a weight loss supplement. Each subject will be given 42 capsules of Swanson super citrimax (hydroxycitrate) Details of the product are provided above. The subjects will be asked to take the capsules over a seven period (6 capsules per day).
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
David Goldfarb, MD · NYU Langone Health
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-04
- Primary Completion
- 2020-12-15
- Completion
- 2020-12-15
Countries
- United States
Study Locations
More Related Trials
-
Effectiveness of Urinary Alkalinizing Agents on Kidney Stone Risk
NCT04095975 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of DASH With Oxalate Restricted Diet on Urine in Recurrent Stone Formers With Hyperoxaluria
NCT01650935 ·Status: COMPLETED ·Phase: NA
-
Dietary Oxalate and Innate Immunity in Kidney Stone Disease
NCT04051346 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
NCT00588120 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Weight Loss on Urinary Oxalate Excretion in Obese Calcium Oxalate Kidney Stone Formers
NCT04633811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
NCT06989320 ·Status: RECRUITING ·Phase: NA
-
Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)
NCT05113641 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Mineral Water for Prevention of Renal Stones
NCT04638166 ·Status: UNKNOWN ·Phase: NA
-
Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling
NCT03281928 ·Status: TERMINATED ·Phase: NA
-
Effects of Potassium Citrate in Urine of Children With Elevated Calcium in Urine and Kidney Stones
NCT00120731 ·Status: WITHDRAWN ·Phase: NA
-
Hydroxyproline Influence on Oxalate Metabolism
NCT02038543 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure
NCT03806998 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation
NCT06681116 ·Status: COMPLETED ·Phase: NA
-
Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers
NCT01088555 ·Status: COMPLETED ·Phase: NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
NCT06331546 ·Status: RECRUITING ·Phase: NA
-
Influence of Obesity on Endogenous Oxalate Synthesis
NCT03704350 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Vinegar Consumption on 24-hour Urinary Risk Factors Associated With Stone Formation
NCT02649140 ·Status: UNKNOWN ·Phase: NA
-
Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria
NCT00004284 ·Status: COMPLETED ·Phase: PHASE3
-
Obesity and Endogenous Oxalate Synthesis
NCT03808090 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria
NCT00283387 ·Status: COMPLETED ·Phase: PHASE2
-
Repletion of Ergothioneine in Patients With Kidney Failure
NCT06487546 ·Status: RECRUITING ·Phase: NA
-
Lipoic Acid Supplement for Cystine Stone
NCT02910531 ·Status: COMPLETED ·Phase: PHASE2
-
Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
NCT00280215 ·Status: WITHDRAWN ·Phase: PHASE3
-
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT04284657 ·Status: COMPLETED ·Phase: PHASE2
-
Vitamin D Repletion in Stone Formers With Hypercalciuria
NCT01295879 ·Status: COMPLETED ·Phase: PHASE4